Welox International

Regonat™ is a quality assured generic of Stivarga® which is used to treat metastatic colon and rectal cancer (CRC) in patients who have been previously treated with certain chemotherapy medicines. It’s also used to treat metastatic gastrointestinal stromal tumors (GIST) in patients who have received other medicines that did not work well. Additionally, it’s indicated for patients with hepatocellular carcinoma (HCC) in people who have been previously treated with sorafenib.

Afanat™ is a quality assured generic of Gilotrif® (also known as Xovoltib®) which is an approved medicine to treat metastatic non–small cell lung cancer (NSCLC) with non–resistant epidermal growth factor receptor (EGFR) mutations. It’s also used for patients with metastatic squamous NSCLC progressing after platinum-based chemotherapy.

Anatero™ is a quality assured generic of Arimidex® which is an approved medicine to treat breast cancer in postmenopausal women by lowering the amount of estrogen in the body. It’s also used for the treatment of advanced breast cancer that has progressed following treatment with tamoxifen in women after menopause.

Lenalid™ is a quality assured generic of Revlimid® which is used in combination with dexamethasone to treat adults with multiple myeloma, smoldering myeloma, and myelodysplastic syndromes, or as maintenance treatment after autologous hematopoietic stem cell transplantation.

Lenalid™ is a quality assured generic of Revlimid® which is used in combination with dexamethasone to treat adults with multiple myeloma, smoldering myeloma, and myelodysplastic syndromes, or as maintenance treatment after autologous hematopoietic stem cell transplantation.

Lenalid™ is a quality assured generic of Revlimid® which is used in combination with dexamethasone to treat adults with multiple myeloma, smoldering myeloma, and myelodysplastic syndromes, or as maintenance treatment after autologous hematopoietic stem cell transplantation.

Introducing Anatero Tablet: Nurturing Breast Health with Precision Aromita Tablet emerges as a pivotal ally in the realm of breast health, designed for the treatment of early breast cancer in postmenopausal women. This versatile medication can be employed alone or in conjunction with other therapies, including surgery or radiation, addressing both early-stage and advanced breast cancer that has spread within the breast or to other areas of the body.
Optimizing Treatment with Aromita Tablet:For optimal results, Aromita Tablet is recommended to be taken irrespective of food, emphasizing the importance of consistent daily intake. Precision in adhering to your doctor's guidance is crucial, as the dose and frequency depend on the specific condition being treated. Gulp down the tablets with a beverage of water, following your doctor's prescription diligently. The duration of the prescribed course should be strictly followed.
Key Applications of Aromita Tablet:
Breast Cancer Treatment:Aromita Tablet takes a leading role in the therapeutic approach to breast cancer, offering its benefits in both early and advanced stages.
Benefits of Aromita Tablet in Breast Cancer Management:Aromita Tablet effectively alleviates symptoms associated with breast cancer, such as breast lumps, abnormal nipple discharge, or changes in the shape or texture of the breast. Operating within the realm of aromatase inhibitors, it modulates the hormones crucial for the growth and spread of breast cancer, potentially interacting with other hormones or directly impacting cancer cells to halt their growth.
Unveiling the Mechanism of Action:Aromita Tablet operates as an aromatase inhibitor, actively reducing the production of estrogen, the natural female hormone, within the body. By doing so, it disrupts or halts the growth of breast cancer cells that rely on estrogen for their development.

Pazonat™ is a quality assured generic of Votrient® which is used to treat people with advanced renal cell cancer (RCC). It’s also used to treat people with advanced soft tissue sarcoma (STS) who have received chemotherapy in the past. It’s not known if Votrient® is effective in treating certain STS and gastrointestinal (GI) tumors.

Geftinat Gefitinib Tablets IP contain Gefitinib, a potent tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC). Gefitinib targets the epidermal growth factor receptor (EGFR) pathway, inhibiting cancer cell proliferation and survival. Geftinat offers a targeted therapy option for patients with EGFR-mutant NSCLC, providing improved outcomes and enhanced quality of life.

Veenat 100 is a targeted oral medication containing Imatinib, a tyrosine kinase inhibitor. It is primarily used in the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs).

X Trant Estramustine Phosphate Capsules are used in the treatment of prostate cancer. This medication combines the properties of an estrogen and a chemotherapy agent, offering a dual mechanism to inhibit cancer cell growth. It is particularly effective in cases where other treatments may not be suitable.

Mabthera 500mg Injection: Pioneering Precision in Disease Management Embark on a transformative journey with Mabthera 500mg Injection, a stalwart in the realm of medical interventions for diverse conditions such as non-Hodgkin lymphoma (NHL), rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis.
Navigating Treatment Realms: Mabthera 500mg Overview
Intricate Administration: Administered as an infusion under the expert guidance of a specialist, Mabthera 500mg Injection epitomizes precision in therapeutic delivery. Dosage and frequency are artfully tailored by your doctor, ensuring a personalized approach to your unique medical journey. Adherence to prescribed regimens is paramount, minimizing the risk of potential side effects.
Exploring Health Horizons: Uses and Benefits
1. Non-Hodgkin Lymphoma (NHL): Mabthera 500mg Injection orchestrates an immune response, contributing to pain and inflammation reduction. The elimination of cancer cells is a pivotal outcome, thwarting their unbridled growth. Foster a lifestyle focused on infection prevention, staying hydrated, and avoiding crowded spaces under the guidance of your healthcare provider.
2. Rheumatoid Arthritis: In the realm of rheumatoid arthritis, Mabthera 500mg Injection emerges as a key player, alleviating inflammation, pain, and swelling by tempering the immune system response. Adherence to prescribed dosage and frequency is imperative. Notify your doctor promptly if you experience fever, chills, or any adverse effects post-administration.
3. Chronic Lymphocytic Leukemia (CLL): Mabthera 500mg Injection stands as a formidable adversary against blood cancer, obstructing cancer cell growth and preventing their proliferation. Candid discussions with your doctor about potential side effects and benefits are essential to informed decision-making.
4. Granulomatosis with Polyangiitis: This condition, characterized by inflammation of various organs, finds relief through Mabthera 500mg Injection. By curbing inflammation, pain, and swelling, this treatment prevents further organ damage, ultimately enhancing your quality of life.
5. Microscopic Polyangiitis: Mabthera 500mg Injection addresses autoimmune challenges, reducing immune responses and inflammation associated with microscopic polyangiitis. This therapeutic intervention promotes healing and alleviates discomfort, ushering in a sense of relief.
Decoding Therapeutic Mechanisms: How Mabthera Operates
Immune Cell Targeting: Mabthera 500mg Injection, a monoclonal antibody, zeroes in on the aberrant activity of immune cells, specifically B cells, in conditions like rheumatoid arthritis and certain cancers. This precise targeting forms the crux of Mabthera's mechanism, providing a tailored response to varied medical challenges

Moostin 40 mg Capsule: Paving the Way in Cancer Treatment
Embark on a transformative journey against cancer with Moostin 40 mg Capsule, an anticancer medication designed to combat various tumors, including brain cancer, lung cancer, Hodgkin's disease, and malignant melanoma. This groundbreaking capsule holds promise for those seeking effective cancer therapy.
Navigating Moostin 40 mg: A Strategic Approach to Treatment
1. Targeting Brain Cancer: Moostin 40 mg Capsule is a formidable adversary against brain cancer. By eliminating or inhibiting the growth of cancer cells, it holds the potential to disrupt the progression of this challenging condition. Adhering to your physician's guidance is crucial, and alcohol consumption should be avoided during treatment to optimize efficacy.
2. Confronting Lung Cancer: Moostin 40 mg Capsule acts decisively against lung cancer, eradicating malignant cells and impeding their further proliferation and spread. Vigilance against infections is advised due to decreased immunity. Adequate fluid intake, a healthy diet, and strict adherence to the prescribed regimen are essential components of comprehensive lung cancer care.
3. Battling Hodgkin's Disease: In Hodgkin's disease, Moostin 40 mg Capsule intervenes by halting the growth of cancer cells and preventing their uncontrolled multiplication. Following your doctor's instructions diligently is paramount for optimal outcomes in the management of Hodgkin's disease.
4. Confronting Malignant Melanoma: Moostin 40 mg Capsule stands as a guardian against malignant melanoma, a highly aggressive form of skin cancer. By disrupting the genetic code within cancer cells, it effectively eliminates them, hindering their growth and spread. This holistic approach contributes to the successful treatment of malignant melanoma.
Unlocking the Mechanism: How Moostin 40 mg Operates
Moostin 40 mg Capsule operates as an anti-cancer powerhouse by inflicting damage to the genetic material (DNA and RNA) within cancer cells. This pivotal action effectively arrests the growth and multiplication of cancer cells, paving the way for a targeted and potent anticancer mechanism.
Guiding Principles for Optimal Results
Strict Adherence: Take Moostin 40 mg Capsule as prescribed by your physician, adhering strictly to the recommended dosage and schedule.
Hydration and Nutrition: Ensure an ample intake of fluids unless otherwise advised by your doctor. Maintain a nutritious diet to complement the therapeutic process.
Vigilance Against Infections: Exercise caution to prevent infections due to decreased immunity during treatment.

Introduction of Cytotam 20 mg tablet:
Cytotam 20 mg tablet is an anti-estrogen medication. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medication helps to slow down the growth and proliferation of cancer cells.
Cytotam 20 mg tablet is also beneficial in the treatment of infertility. It can be taken regardless of food, but it is recommended to take it at a consistent time to maximize the benefits. It should be taken as per your physician's advice. The dosage and frequency of intake depend on the purpose for which you are taking it. Your doctor will determine how much you need to improve your symptoms. Swallow the tablets with a drink of water. This medication is generally taken for 5 to 10 years. You should take this medication for as long as it is prescribed for you.
Uses of Cytotam 20 mg tablet:
In breast cancerBenefits of Cytotam 20 mg tablet:
In breast cancer:
Cytotam 20 mg tablet alleviates the symptoms of breast cancer, such as breast lumps, bloody discharge from the nipple, or changes in the shape or texture of the breast. It works by altering the production of certain hormones in the body that are essential for the growth and spread of breast cancer, both in pre- and postmenopausal women. It may also interact with other hormones or directly affect the cancer to halt its growth.
Mechanism of action of Cytotam 20 mg tablet:
Cytotam 20 mg tablet is a hormone-based medicine. It works by binding to estrogen receptors and blocking the effects of estrogen (a natural female hormone) in the breast tissue. This slows down the growth and proliferation of breast cancer cells.

Introduction of Caditam 20 mg tablet:
Caditam 20 mg tablet is an anti-estrogen medication. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medication helps to slow down the growth and proliferation of cancer cells.
Caditam 20 mg tablet is also beneficial in the treatment of infertility. It can be taken regardless of food, but find time to get the most benefit. It should be taken as per your physician's advice. The dosage and frequency depend on the purpose for which you are taking it. Your doctor will determine how much you need to improve your symptoms. Swallow the tablets with a drink of water. This medication is generally taken for 10 to 15 years. You should take this medication for as long as it is prescribed for you.
Uses of Caditam 20 mg tablet:Breast cancer

Benefits of Caditam 20 mg tablet:
In breast cancer:
Caditam 20 mg tablet alleviates the symptoms of breast cancer, such as breast lumps, abnormal discharge from the nipple, or changes in the shape or texture of the breast. It works by altering the production of those chemicals in the body that are essential for the growth and spread of breast cancer, both in pre- and postmenopausal women. It may also interact with other chemicals or directly affect the cancer to halt its growth.
Mechanism of action of Caditam 20 mg tablet:
Caditam 20 mg tablet is a hormonal-based medicine. It works by binding to estrogen receptors and blocking the effects of estrogen (a natural female hormone) in the breast tissue. This slows down the growth and proliferation of breast cancer cells.

Zoldonat Zoledronic Acid / Zoledronate (4.0 Mg) Injection is a potent treatment for bone disorders such as osteoporosis and skeletal-related events in cancer patients. This injection contains 4.0 mg of zoledronic acid, a bisphosphonate that inhibits bone resorption and helps strengthen bone density. Trusted for its efficacy and safety, Zoldonat is essential for managing bone health and preventing fractures.

Introduction to Gefticip 250mg Tablets:
Gefticip Tablet is prescribed for the treatment of non-small cell lung cancer. It is particularly effective for patients whose cancer has metastasized to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not undergone prior treatment for cancer.
Administration of Gefticip 250mg Tablets:
Gefticip Tablet can be taken with or without food, although taking it at the same time every day is recommended for optimal results. It is important to continue taking the medication for as long as your doctor advises. The duration of treatment varies depending on your individual needs and response to therapy. Take the medication exactly as prescribed by your doctor, as taking too much can lead to severe side effects. It may take several weeks or months to see or feel the benefits, so do not discontinue the medication unless instructed by your doctor.
Uses of Gefticip 250mg Tablets:
Gefticip 250mg Tablets are primarily used for:
Non-small cell lung cancer

Benefits of Gefticip 250mg Tablets:
In Non-small Cell Lung Cancer:Non-small cell lung cancer is a major type of lung cancer that affects both smokers and non-smokers. Gefticip Tablet helps treat non-small cell lung cancer and may be administered alone or in combination with other medications. It is a potent and highly effective drug, and it's important to discuss the risks and benefits with your doctor. Avoiding alcohol consumption while undergoing this treatment and staying hydrated by drinking plenty of water is recommended.

Mechanism of Action of Gefticip 250mg Tablets:
Gefticip Tablet is an anti-cancer medication that works by inhibiting the action of abnormal proteins that signal cancer cells to multiply. This helps to halt or slow down the spread of cancer cells.

Introduction of Imutrex 10 mg Tablet:
Imutrex 10 mg Tablet is a medication used to treat rheumatoid arthritis, where it prevents further joint damage. It is also used to treat severe forms of a skin disease called psoriasis, where it works by eliminating cells in the skin that grow too quickly.
Imutrex 10 mg Tablet may be used alone or in combination with other medications. You should take it exactly as your physician has advised. Taking too much of it can cause serious side effects. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your physician tells you to. You should avoid drinking alcohol while taking this medication as it may increase your risk of liver damage.
Uses of Imutrex 10 mg Tablet:
Treatment of Rheumatoid arthritisTreatment of Psoriasis

Benefits of Imutrex 10 mg Tablet:
In Treatment of Rheumatoid arthritis:Imutrex 10 mg Tablet belongs to a group of medications called antimetabolites. It may be used to treat severe rheumatoid arthritis if other treatments have previously been tried and have not worked. It is not a first-line treatment. It works by reducing the body's immune system; this reduces swelling, decreases pain, stiffness, and improves function. Take it exactly as prescribed and for as long as getting the most benefit is prescribed.
In Treatment of Psoriasis:Imutrex 10 mg Tablet belongs to a group of medications called antimetabolites. It may be used to treat severe psoriasis when other treatments have not worked. Psoriasis is a condition where the skin cells in the body grow too fast. Imutrex 10 mg Tablet works by eliminating these rapidly growing cells. It is a potent and highly toxic drug, and you should discuss the risks and benefits with your physician. Take it exactly as prescribed and for as long as getting the most benefit is prescribed.
Mechanism of action of Imutrex 10 mg Tablet:
Imutrex 10 mg Tablet is an immunosuppressant. In rheumatoid arthritis, it works by reducing the activity of the body's immune system. This reduces swelling, decreases pain and stiffness, and improves function. In psoriasis, it works by slowing down the rapid growth of skin cells.

Bdron™ is a quality assured generic of Zytiga® which is approved to treat prostate cancer. It is used in combination with prednisone for the treatment of metastatic castration resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adult men.

Bdron™ is a quality assured generic of Zytiga® which is approved to treat prostate cancer. It is used in combination with prednisone for the treatment of metastatic castration resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC) in adult men.

Bdenza™ is a quality assured generic of Xtandi® which is used treat castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC).

Acabrunat™ is a quality assured generic of Calquence® which is an approved cancer medicine to treat mantle cell lymphoma (MCL) in adults who have had previous treatment for their cancer at least once. It is also used as a treatment for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Bdenza™ is a quality assured generic of Xtandi® which is used treat castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC).

Lanib™ is a quality assured generic of Tykerb® which is used in combination therapy for the treatment of advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 (HER2).

Temotero™ is a quality assured generic of Temodar® which is used to treat certain brain cancer tumors. It’s indicated for patients with newly diagnosed glioblastoma along with radiotherapy and then as maintenance treatment. It’s also indicated for patients with refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.

Erlotero™ is a quality assured generic of Tarceva® which is used as a monotherapy to treat advanced non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene-activating mutations. It’s also used to treat advanced pancreatic cancer in combination with chemotherapy.

Erlotero™ is a quality assured generic of Tarceva® which is used as a monotherapy to treat advanced non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene-activating mutations. It’s also used to treat advanced pancreatic cancer in combination with chemotherapy.

Sutinat™ is a quality assured generic of Sutent® which is used to treat advanced renal cell carcinoma (RCC). It’s also used to treat gastrointestinal stromal tumor (GIST) after the patient had taken imatinib and it didn’t work well or can not take it. Additionally, it’s used to treat  pancreatic neuroendocrine tumor (pNET) that has progressed and cannot be surgically removed. Moreover, it’s used to treat kidney cancer that has not spread (localized) in adults who are at high risk of the cancer coming back after kidney surgery.

Soranib™ is a quality assured generic of Nexavar® which is approved to treat a type of liver cancer called hepatocellular carcinoma (HCC) that cannot be removed by surgery, and a type of kidney cancer called renal cell carcinoma (RCC), and a type of thyroid cancer called differentiated thyroid carcinoma (DTC) that can no longer be treated with radioactive iodine and is progressing.

Pomalid™ is a quality assured generic of Pomalyst® (aka Imnovid). It’s used in combination with dexamethasone to treat multiple myeloma (cancer of the blood) in adults who have previously received at least 2 other medicines and whose disease has worsened during treatment or within 2 months of the last treatment. It’s also used to treat Kaposi sarcoma. This medicine should be used under a doctor’s supervision within a REMS (Risk Evaluation and Mitigation Strategy) program.

Pomalid™ is a quality assured generic of Pomalyst® (aka Imnovid). It’s used in combination with dexamethasone to treat multiple myeloma (cancer of the blood) in adults who have previously received at least 2 other medicines and whose disease has worsened during treatment or within 2 months of the last treatment. It’s also used to treat Kaposi sarcoma. This medicine should be used under a doctor’s supervision within a REMS (Risk Evaluation and Mitigation Strategy) program.

Bracanat™ is a quality assured generic of Lynparza® which is used to treat advanced ovarian cancer, fallopian tube cancer, and primary peritoneal cancer in women with an abnormal BRCA gene. It’s also used to treat metastatic HER2-negative breast cancer before or after chemotherapy or hormonal treatment. Additionally, it’s used to treat prostate cancer with specific abnormal genes. Moreover, it’s used to treat pancreatic cancer in patients with a specific abnormal inherited gene.

Bdbrut™ is a quality assured generic of Imbruvica® which is used treat chronic lymphocytic leukemia (CLL)/Small lymphocytic lymphoma (SLL) in adults including those with 17p deletion. It’s also used to treat mantle cell lymphoma (MCL) in adults who have received at least one prior treatment. Furthermore, it’s used to treat marginal zone lymphoma (MZL) in adult patients who require systemic therapy and have received a specific prior treatment. Moreover, it’s used to treat Waldenström’s macroglobulinemia (WM) in adults. Additionally, it’s used to treat chronic graft-versus-host disease (cGHVD) after failure of prior treatment in adults and children.

Veenat™ is a quality assured generic of Gleevec® which is used alone or together with other medicines to treat these different types of cancer and bone marrow conditions:
– Aggressive systemic mastocytosis (ASM)
– Chronic eosinophilic leukemia (CEL)
– Dermatofibrosarcoma protuberans (DFSP)
– Gastrointestinal stromal tumors (GIST)
– Hypereosinophilic syndrome (HES)
– Myelodysplastic syndrome (MDS)
– Myeloproliferative diseases (MPD)
– Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
– Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML)

Dyronib™ is a quality assured generic of Sprycel® which is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children. It is also used to treat Ph+ CML and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults with resistance or intolerance to prior therapy including imatinib. It’s also indicated for the treatment of pediatric patients 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy.

Dasanat™ is a quality assured generic of Sprycel® which is used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase in adults and children 1 year of age and older. It’s also used to treat Ph+ acute lymphoblastic leukemia (Ph+ ALL) in adults with resistance or intolerance to other treatments. Furthermore, it’s indicated for the treatment of children 1 year of age and older with Ph+ ALL in combination with chemotherapy.

Cabozanib™ is a quality assured generic of Cabometyx® which is used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine.

Cabozanib™ is a quality assured generic of Cabometyx® which is used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine.

Cabozanib™ is a quality assured generic of Cabometyx® which is used to treat advanced renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC) in patients who were previously treated with sorafenib. It’s also used to treat differentiated thyroid cancer (DTC) that has progressed after VEGFR-targeted treatment in patients who can no longer be treated with radioactive iodine.

Bandrone™ is a quality assured generic of Boniva® which is used to treat and prevent osteoporosis (weakness of the bones) in adults. It’s also used to treat metastasis-associated skeletal fractures in adults with cancer.